Luminex, a manufacturer of biological testing technologies, has acquired EraGen Biosciences for $34m.

EraGen Biosciences products, based on its novel, patented MultiCode platform chemistry, are next generation DNA- and RNA-based testing for the early detection of infectious diseases and genetic-based conditions.

Luminex with its proprietary biological testing technologies has applications throughout the diagnostic and life sciences industries.

Luminex’s xMAP multiplex solutions include a technology platform that delivers bioassay results to pharmaceutical drug discovery, clinical diagnostics and biomedical research, including genomic and proteomic research markets.